OtherArticle
Pioglitazone and Rosiglitazone decrease PGE2 in non-small cell lung cancer cells by upregulating 15-hydroxyprostaglandin dehydrogenase
Saswati Hazra, Raj K Batra, Hsin H Tai, Sherven Sharma, Xiaoyan Cui and Steven M Dubinett
Molecular Pharmacology April 5, 2007, DOI: https://doi.org/10.1124/mol.106.033357
Saswati Hazra
Raj K Batra
Hsin H Tai
Sherven Sharma
Xiaoyan Cui
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
OtherArticle
Pioglitazone and Rosiglitazone decrease PGE2 in non-small cell lung cancer cells by upregulating 15-hydroxyprostaglandin dehydrogenase
Saswati Hazra, Raj K Batra, Hsin H Tai, Sherven Sharma, Xiaoyan Cui and Steven M Dubinett
Molecular Pharmacology April 5, 2007, DOI: https://doi.org/10.1124/mol.106.033357
OtherArticle
Pioglitazone and Rosiglitazone decrease PGE2 in non-small cell lung cancer cells by upregulating 15-hydroxyprostaglandin dehydrogenase
Saswati Hazra, Raj K Batra, Hsin H Tai, Sherven Sharma, Xiaoyan Cui and Steven M Dubinett
Molecular Pharmacology April 5, 2007, DOI: https://doi.org/10.1124/mol.106.033357
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement